AVITA Medical (AVHHL) Long-Term Investments (2021 - 2023)

AVITA Medical (AVHHL) has reported Long-Term Investments for 3 consecutive years, with $2.8 million the latest figure, recorded in Q2 2023.

• For the quarter ending Q2 2023, Long-Term Investments fell 59.16% year-over-year to $2.8 million; the trailing twelve-month figure through Jun 2023 stood at $2.8 million (down 59.16% YoY), and the FY2022 full-year result was $6.9 million, down 64.81% from the prior year.
• Long-Term Investments eased to $2.8 million in Q2 2023 per AVHHL's latest filing, from $4.2 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $19.8 million in Q3 2021 and bottomed at $2.8 million in Q2 2023.
• Historically, Long-Term Investments has averaged $9.5 million across 3 years, with a median of $6.8 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Long-Term Investments sank 79.74% in 2022, then plunged 59.16% in 2023.
• Over 3 years, Long-Term Investments stood at $19.7 million in 2021, then sank by 64.81% to $6.9 million in 2022, then tumbled by 60.26% to $2.8 million in 2023.
• According to Business Quant data, Long-Term Investments over the past three periods registered $2.8 million, $4.2 million, and $6.9 million for Q2 2023, Q1 2023, and Q4 2022 respectively.